A new anti-obesity drug from Pfizer has high rates of side effects
However, Pfizer announced its intention to develop a modified version of the drug called "danoglibron." This drug belongs to a ...
However, Pfizer announced its intention to develop a modified version of the drug called "danoglibron." This drug belongs to a ...
Governments of low- and middle-income countries are guided when making purchasing decisions by the List of Essential Medicines. Next month, ...